Stakeholders Look To Congress For 340B Reform After HRSA Pulls 'Mega-Rule'

The Health Resources and Services Administration's decision to pull back its anticipated “mega-reg” and instead release guidance in 2015 leaves some stakeholders looking to Congress for major changes to the 340B program, with the drug industry lobby already urging lawmakers to get involved. “While we look forward to the guidance to be issued by HRSA, we believe that the fundamental problems of the program still need to be addressed by Congress, and we agree with HRSA that Congress needs to...